CDH2 and esophageal cancer: Furthermore, while ACVRIB loss has not been described to contribute to esophageal cancer, the overexpression of Activin A has been identified previously to be associated with enhanced matrix metalloprotease expression [26] and ESCC aggressiveness [65], partially through upregulated of N-cadherin [24].